Who we are ?

Lariox Pharma is the newest gem in the AbdelMaksoud pharmaceutical legacy, established in 2018. We leverage over 60 years of experience in the pharmaceutical sector, encompassing prestigious pharmacy chains, a state-of-the-art aerosol manufacturing facility, and a deep understanding of the local market.

We are a B2B Regulatory service provider, combining the wisdom of experience with a modern approach. Our team is acutely aware of the latest regulations, ensuring your business remains compliant and avoids costly delays.

Our Vision:

• To be your end-to-end solution for regulatory affairs, pharmacovigilance, and training.
• To provide exceptional value through reasonable costs and unwavering quality.
• To embody integrity, discipline, and confidentiality in everything we do.
• To design science-based solutions that propel your products to quicker market access (QMA).

Our Mission:

Empowering your success by navigating the complexities of regulatory affairs and pharmacovigilance. We ensure your products reach patients safely and efficiently.
 

 Why Choose Lariox Pharma? 

• Expert regulatory team ensures smooth license & registration processes.
• We handle the complexities, so you can focus on running your business.
• Customized solutions to fit your specific needs and minimize risks.
• Free up your time and resources for core business development activities.
   

Lariox Pharma Leadership Team

Meet the experienced professionals guiding Lariox Pharma's success:

• Dr. Essam Aly Abdelmaksoud, CEO: With over 50 years of experience, Dr. Abdelmaksoud brings a wealth of knowledge in pharmaceuticals, commercial operations, and international trade. He has overseen pharmacy chains and managed the import and export of medical devices and food supplements.
   
• Dr. Marwa Ibrahim, Senior Vice President, Regulatory Affairs: Dr. Ibrahim has more than 20 years of experience in regulatory affairs within multinational companies. She holds an MBA and is a valuable asset in navigating the complexities of global regulations.
   
• Dr. Nadeen Essam, Senior Vice President, Pharmacovigilance: Dr. Essam brings over 20 years of experience in government affairs and project management for biological and biosimilar projects. She is a certified QPPV (Qualified Person for Pharmacovigilance) with 6 years of deep expertise in various areas of pharmacovigilance